Jefferies Group LLC Invitae Corp Transaction History

Jefferies Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $69,246 - $292,915	-32,510 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $204,162 - $506,830	32,510 New	32,510 $0
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.57 Million - $2.43 Million	-60,168 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$33.06 - $56.93 $1.99 Million - $3.43 Million	60,168 New	60,168 $2.3 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $1.99 Million - $3.43 Million	60,168 New	60,168 $2.3 Million

Q4 2019 Feb 13, 2020	SELL	$15.02 - $20.57 $360,855 - $494,194	-24,025 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$18.85 - $27.5 $452,871 - $660,687	24,025 New	24,025 $463,000
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $521,100 - $788,100	-30,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $196,066 - $474,057	18,410 Added 158.84%	30,000 $703,000
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $54,726 - $96,805	-5,910 Reduced 33.77%	11,590 $128,000
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $131,950 - $320,425	17,500 New	17,500 $293,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.